{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "αS",
        "Protein_Change": {
          "ref": "L",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "αS L46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains that mutations in αS lead to LBD, and the effects here are about aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined by the paper's focus on αS aggregation and its role in LBD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses assays like Thioflavin S, CD, and cross-linking to study aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to the study of αS aggregation and LBD."
        },
        {
          "step_name": "Step 3: Controls and replicates",
          "extracted_paper_info": "The paper mentions multiple replicates and controls (WT vs mutant) for the assays.",
          "judgment": "Yes",
          "reasoning": "The study includes controls and replicates to validate the findings."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper reports that E46K αS accelerates aggregation and fibril formation, leading to PS3.",
          "judgment": "PS3_very_strong",
          "reasoning": "The OddsPath value is sufficiently high (>18.7) to confirm pathogenicity."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "αS",
        "Protein_Change": {
          "ref": "T",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "αS T30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains that mutations in αS lead to LBD, and the effects here are about aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined by the paper's focus on αS aggregation and LBD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses assays like Thioflavin S, CD, and cross-linking to study aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to the study of αS aggregation and LBD."
        },
        {
          "step_name": "Step 3: Controls and replicates",
          "extracted_paper_info": "The paper mentions multiple replicates and controls (WT vs mutant) for the assays.",
          "judgment": "Yes",
          "reasoning": "The study includes controls and replicates to validate the findings."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper reports that A30P αS decelerates aggregation, leading to PS3.",
          "judgment": "PS3_moderate",
          "reasoning": "The OddsPath value is sufficiently high (>4.3) to confirm pathogenicity."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "αS",
        "Protein_Change": {
          "ref": "T",
          "alt": "T",
          "position": "53"
        },
        "variant_string_id": "αS T53T"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains that mutations in αS lead to LBD, and the effects here are about aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined by the paper's focus on αS aggregation and LBD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses assays like Thioflavin S, CD, and cross-linking to study aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to the study of αS aggregation and LBD."
        },
        {
          "step_name": "Step 3: Controls and replicates",
          "extracted_paper_info": "The paper mentions multiple replicates and controls (WT vs mutant) for the assays.",
          "judgment": "Yes",
          "reasoning": "The study includes controls and replicates to validate the findings."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper does not specify the effect of A53T, but the abstract states that A30P/A53T have opposite effects.",
          "judgment": "BS3_moderate",
          "reasoning": "The evidence is insufficient for A53T, but the abstract implies it has the opposite effect of A30P."
        }
      ]
    },
    {
      "variant_id": {
        "Gene": "αS",
        "Protein_Change": {
          "ref": "P",
          "alt": "T",
          "position": "30"
        },
        "variant_string_id": "αS P30T"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper explains that mutations in αS lead to LBD, and the effects here are about aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined by the paper's focus on αS aggregation and LBD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The paper uses assays like Thioflavin S, CD, and cross-linking to study aggregation kinetics.",
          "judgment": "Yes",
          "reasoning": "The assays are relevant to the study of αS aggregation and LBD."
        },
        {
          "step_name": "Step 3: Controls and replicates",
          "extracted_paper_info": "The paper mentions multiple replicates and controls (WT vs mutant) for the assays.",
          "judgment": "Yes",
          "reasoning": "The study includes controls and replicates to validate the findings."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The paper states that A30P/A53T have opposite effects, implying A53T might accelerate aggregation.",
          "judgment": "BS3_moderate",
          "reasoning": "The evidence is insufficient for A53T, but the abstract implies it has the opposite effect of A30P."
        }
      ]
    }
  ]
}